Infectious history as a determinant of age-related inflammation in Alzheimers disease
感染史是阿尔茨海默病年龄相关炎症的决定因素
基本信息
- 批准号:10663042
- 负责人:
- 金额:$ 19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffectAgeAge-associated memory impairmentAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAnimal ExperimentationAnimal ModelAnimalsAreaAstrocytesBrainCD8B1 geneCell CommunicationCell modelCellsCentral Nervous SystemChronicCicatrixComplexDataDementiaDevelopmentDiseaseDisease ProgressionEncephalitisEnvironmentEnvironmental Risk FactorEpigenetic ProcessEtiologyExposure toGeneticGenetic Predisposition to DiseaseGenetic TranscriptionGoalsGrantHealthHippocampusHousingImmuneImmune responseImmune systemImpaired cognitionIndividualInfectionInflammagingInflammationInflammation MediatorsInflammatoryInterferon Type IIInterferonsKnowledgeLeadLinkLong-Term EffectsMacrophageMemoryMetabolicMicrobeMicrogliaMusMyeloid CellsNerve DegenerationNeurobiologyNeurodegenerative DisordersNeurogliaNeuronsPathogenesisPathogenicityPathologicPathologyPeripheralPhenotypePhysiologicalPlayPre-Clinical ModelProductionReactionRecording of previous eventsResearch PersonnelRiskRisk FactorsRoleSourceSterilitySymptomsT cell infiltrationT memory cellT-Cell ReceptorT-LymphocyteTestingTimeTissuesViralVirus DiseasesWorkacute infectionadaptive immunityage relatedage related neurodegenerationaging brainbrain healthbrain tissuecytokinecytotoxicepigenomeepigenomicsgerm free conditionhigh rewardhigh riskimmune cell infiltrateimmune functionimmunological statusinflammatory markermouse modelneuroinflammationneuron lossnovelpathogenprotective factorsresponsestemtau Proteinstissue resident memory T cell
项目摘要
Project Summary
Alzheimer’s disease (AD) is a complex disease driven by genetic and environmental components, which converge
upon inflammation as a common driver. Notably, inflammatory insults to the central nervous system (CNS), such
as viral infection, are correlated with AD and other forms of cognitive decline although the mechanisms linking
prior neuroinflammatory exposure to later AD development are unclear. Pathogenic infection leads to profound
remodeling of tissues that can have long-term effects on the composition of immune cells in tissues including
inflammatory and epigenetic states. For example, after infection, memory T cells infiltrate and persist in the brain
long-term as tissue-resident memory T (TRM) cells. While TRM cells provide protection against re-infection in tissues,
their presence can also lead to dysregulated inflammation. Moreover, the brain resident macrophages, microglia,
and astrocytes can be functionally and epigenetically reprogrammed after exposure to infection, leaving the cells
poised to produce inflammatory mediators upon re-infection. While protective to re-infection, these poised
inflamed states of brain TRM cells and glia may put the brain at risk of potentially elevated and harmful inflammation.
Nearly all AD animal research is performed in animals in specific- pathogen free (SPF) conditions, protected from
exposure to environmentally-relevant microbes. Therefore, this project aims to develop more physiological AD
models by examining how successive viral infections remodel the CNS and brain-resident microglia, astrocytes
and TRM cells, to test if this increases brain inflammation and hastens neurodegeneration and AD pathogenesis.
To this end, mice genetically predisposed to develop AD-like symptoms will be serially infected with different
pathogens over the first half of their lifetime to replicate exposure to multiple pathogens over one’s lifetime. As the
mice age, they will be examined for changes in the composition, transcription, epigenome and function of immune
cells, glia, and neurons, and look for earlier signs of AD pathology and dementia. This application will test if a
history of infection increases age- related inflammation in the CNS, such as Type I and Type II interferons. By
defining pathological links between serial infection, chronic inflammation, and brain resident immune cells, these
studies will address this gap in knowledge between one’s infection history and age-related inflammation in the
brain that supports AD pathogenesis, and define environmental drivers of sporadic AD. Furthermore, these studies
will shed light on the role of brain TRM cells and how they regulate the inflammatory tone of the brain. Considering
that most cases of AD are sporadic, and it is an irreversible pathology that currently lacks therapies, it is crucial
to elucidate more precisely how environmental factors and the immune system are involved in this disease. Thus,
the goal of this grant is to develop more physiologically relevant pre-clinical models that can better inform how the
immune response and inflammation contribute to AD and neuronal health with age.
项目摘要
阿尔茨海默氏病(AD)是一种由遗传和环境成分驱动的复杂疾病,转化
在炎症作为常见驱动器时。值得注意的是,对中枢神经系统(CNS)的炎症性侮辱,这样
作为病毒感染,尽管机制联系在一起,但与AD和其他形式的认知下降相关
事先神经炎症性暴露于后来的AD发育尚不清楚。致病感染导致深刻
对组织中可能对组织中免疫细胞组成产生长期影响的组织的重塑
炎症和表观遗传状态。例如,感染后,记忆T细胞浸润并持续在大脑中
长期作为组织居民记忆t(TRM)细胞。虽然TRM细胞可防止在时机中重新感染,但
它们的存在也会导致注射失调。此外,大脑居民巨噬细胞,小胶质细胞,
暴露于感染后,可以在功能和表观遗传上进行重新编程,使细胞在功能和表观上进行重编程
准备在重新感染后产生炎症介质。在保护重新感染的同时,这些中毒
脑TRM细胞和神经胶质的发炎状态可能会使大脑处于潜在升高和有害感染的风险。
几乎所有的AD动物研究都是在特定病原体(SPF)条件下进行的动物进行的,受到保护
暴露于与环境相关的微生物。因此,该项目旨在开发更多的物理广告
通过检查成功的病毒感染如何重塑中枢神经系统和脑居民小胶质细胞,星形胶质细胞
和TRM细胞,以测试这是否增加了脑感染并加速神经退行性和AD发病机理。
为此,通常倾向于发展出广告样症状的小鼠将被不同的症状感染
在他们一生的上半年,病原体在一生中复制多种病原体。作为
小鼠年龄,将检查它们的成分,转录,表观基因组和免疫功能的变化
细胞,神经胶质和神经元,并寻找早期的AD病理学和痴呆症的迹象。此应用程序将测试是否
感染史增加了中枢神经系统中与年龄相关的感染,例如I型和II型干扰素。经过
定义连续感染,慢性感染和脑居民免疫核管之间的病理联系,这些
研究将解决一个人的感染历史与年龄相关的炎症之间的知识差距
支持AD发病机理并定义零星AD的环境驱动因素的大脑。此外,这些研究
将阐明脑TRM细胞的作用以及它们如何调节大脑的炎症音调。考虑
大多数AD病例都是零星的,它是目前缺乏治疗的不可逆病理学,这是至关重要的
更精确地阐明环境因素和免疫系统如何参与该疾病。那,
这笔赠款的目的是开发更具身体相关的临床前模型,以更好地告知
随着年龄的增长,免疫反应和炎症会导致AD和神经元健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan M Kaech其他文献
Susan M Kaech的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan M Kaech', 18)}}的其他基金
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
核心1:肿瘤与微环境异质性核心(TMH核心)
- 批准号:
10629067 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
项目 3:慢性干扰素和胆汁酸信号传导作为年龄相关性肝癌免疫抑制的驱动因素
- 批准号:
10270688 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
项目 3:慢性干扰素和胆汁酸信号传导作为年龄相关性肝癌免疫抑制的驱动因素
- 批准号:
10698108 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
了解癌症中的代谢异质性如何影响肿瘤微环境和抗肿瘤免疫
- 批准号:
9981453 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
了解癌症中的代谢异质性如何影响肿瘤微环境和抗肿瘤免疫
- 批准号:
10570962 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
了解癌症中的代谢异质性如何影响肿瘤微环境和抗肿瘤免疫
- 批准号:
10335143 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
了解癌症中的代谢异质性如何影响肿瘤微环境和抗肿瘤免疫
- 批准号:
10747827 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
了解并克服由于抗原存在缺陷而对癌症免疫治疗产生的耐药性
- 批准号:
10337040 - 财政年份:2019
- 资助金额:
$ 19万 - 项目类别:
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
了解并克服由于抗原存在缺陷而对癌症免疫治疗产生的耐药性
- 批准号:
10559608 - 财政年份:2019
- 资助金额:
$ 19万 - 项目类别:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
(PQ5) 黑色素瘤肿瘤和免疫反应中的线粒体异质性
- 批准号:
9900670 - 财政年份:2018
- 资助金额:
$ 19万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别: